Literature DB >> 12194918

Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors.

John B Whitfield1, Gu Zhu, John E Nestler, Andrew C Heath, Nicholas G Martin.   

Abstract

BACKGROUND: Several studies have shown that variation in serum gamma-glutamyltransferase (GGT) in the population is associated with risk of death or development of cardiovascular disease, type 2 diabetes, stroke, or hypertension. This association is only partly explained by associations between GGT and recognized risk factors. Our aim was to estimate the relative importance of genetic and environmental sources of variation in GGT as well as genetic and environmental sources of covariation between GGT and other liver enzymes and markers of cardiovascular risk in adult twin pairs.
METHODS: We recruited 1134 men and 2241 women through the Australian Twin Registry. Data were collected through mailed questionnaires, telephone interviews, and by analysis of blood samples. Sources of variation in GGT, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) and of covariation between GGT and cardiovascular risk factors were assessed by maximum-likelihood model-fitting.
RESULTS: Serum GGT, ALT, and AST were affected by additive genetic and nonshared environmental factors, with heritabilities estimated at 0.52, 0.48, and 0.32, respectively. One-half of the genetic variance in GGT was shared with ALT, AST, or both. There were highly significant correlations between GGT and body mass index; serum lipids, lipoproteins, glucose, and insulin; and blood pressure. These correlations were more attributable to genes that affect both GGT and known cardiovascular risk factors than to environmental factors.
CONCLUSIONS: Variation in serum enzymes that reflect liver function showed significant genetic effects, and there was evidence that both genetic and environmental factors that affect these enzymes can also affect cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12194918

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  32 in total

1.  Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.

Authors:  Rohit Loomba; Fangwen Rao; Lian Zhang; Srikrishna Khandrika; Michael G Ziegler; David A Brenner; Daniel T O'Connor
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

2.  Serum γ-Glutamyltransferase, Alanine Aminotransferase and Aspartate Aminotransferase Activity in Healthy Blood Donor of Different Ethnic Groups in Gorgan.

Authors:  Abdoljalal Marjani; Masoumeh Mehrpouya; Zeinab Pourhashem
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 3.  Genome-wide association studies and genetic risk assessment of liver diseases.

Authors:  Marcin Krawczyk; Roman Müllenbach; Susanne N Weber; Vincent Zimmer; Frank Lammert
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

4.  Loci affecting gamma-glutamyl transferase in adults and adolescents show age × SNP interaction and cardiometabolic disease associations.

Authors:  Rita P Middelberg; Beben Benyamin; Marleen H M de Moor; Nicole M Warrington; Scott Gordon; Anjali K Henders; Sarah E Medland; Dale R Nyholt; Eco J C de Geus; Jouke J Hottenga; Gonneke Willemsen; Lawrence J Beilin; Trevor A Mori; Margaret J Wright; Andrew C Heath; Pamela A F Madden; Dorret I Boomsma; Craig E Pennell; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-10-18       Impact factor: 6.150

Review 5.  Genetic insights into cardiometabolic risk factors.

Authors:  John B Whitfield
Journal:  Clin Biochem Rev       Date:  2014-02

Review 6.  Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

7.  The genetic architecture of liver enzyme levels: GGT, ALT and AST.

Authors:  Jenny H D A van Beek; Marleen H M de Moor; Eco J C de Geus; Gitta H Lubke; Jacqueline M Vink; Gonneke Willemsen; Dorret I Boomsma
Journal:  Behav Genet       Date:  2013-04-12       Impact factor: 2.805

8.  Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study.

Authors:  Maria Franzini; Irene Fornaciari; Jian Rong; Martin G Larson; Claudio Passino; Michele Emdin; Aldo Paolicchi; Ramachandran S Vasan
Journal:  Clin Chim Acta       Date:  2012-12-14       Impact factor: 3.786

9.  Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors.

Authors:  Tanushree Bose; V Saroja Voruganti; M Elizabeth Tejero; J Michael Proffitt; Laura A Cox; John L VandeBerg; Michael C Mahaney; Jeffrey Rogers; Jeanne H Freeland-Graves; Shelley A Cole; Anthony G Comuzzie
Journal:  Exp Biol Med (Maywood)       Date:  2009-12

10.  Epidemiology and genetic epidemiology of the liver function test proteins.

Authors:  Nilufer Rahmioglu; Toby Andrew; Lynn Cherkas; Gabriela Surdulescu; Ramasamyiyer Swaminathan; Tim Spector; Kourosh R Ahmadi
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.